Belimumab in Remission of VASculitis

NCT01663623 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasculitis

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: Belimumab 10 mg/kg
DRUG: Azathioprine

Sponsor

Human Genome Sciences Inc., a GSK Company

Collaborators

[object Object]